Influence of exogenous growth hormone administration on circulating levels of Klotho in healthy and CKD subjects

Trial Profile

Influence of exogenous growth hormone administration on circulating levels of Klotho in healthy and CKD subjects

Recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Jul 2016

At a glance

  • Drugs Somatropin (Primary)
  • Indications Cardiovascular disorders; Renal failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top